Foresite Capital Management III, LLC 13F Holdings · last filed Q3 2022
Foresite Capital Management III, LLC reported 4 securities worth $37.88M in its SEC 13F filing for Q3 2022 (period ended 2022-09-30). Top holdings: ASND (36.44%), VRNA (29.98%), NTRA (18.41%).
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | ASND | Ascendis Pharma A/S | $13.8M | 36.44% | 133,691 | Hold |
| 2 | VRNA | Verona Pharma PLC. | $11.4M | 29.98% | 1.1M | Hold |
| 3 | NTRA | Natera, Inc. | $7.0M | 18.41% | 159,160 | Hold |
| 4 | CBAY | Cymabay Therapeutics, Inc. | $5.7M | 15.17% | 1.6M | Hold |
Source: SEC Form 13F filings · as of 2022-09-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR